Edge Capital Group, LLC Amgen Inc Transaction History

Edge Capital Group, LLC

$1.99 Billion
Q1 2024

A detailed history of Edge Capital Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Edge Capital Group, LLC holds 5,445 shares of AMGN stock, worth $1.68 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,445

Previous 5,725 4.89%

Holding current value

$1.68 Million

Previous $1.65 Million 6.07%

% of portfolio

0.08%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $75,283 - $90,876	-280 Reduced 4.89%	5,445 $1.55 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $88,727 - $100,095	-347 Reduced 5.71%	5,725 $1.65 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $162,238 - $201,423	-742 Reduced 10.89%	6,072 $1.63 Million
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $81,636 - $96,533	381 Added 5.92%	6,814 $1.51 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $198,469 - $241,900	879 Added 15.83%	6,433 $1.56 Million

Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $1,145 - $1,455	5 Added 0.09%	5,554 $1.46 Million
Q3 2022 Nov 09, 2022	SELL	$224.46 - $253.15 $2,244 - $2,531	-10 Reduced 0.18%	5,549 $1.25 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $2,076 - $2,310	9 Added 0.16%	5,559 $1.35 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $11,840 - $13,098	54 Added 0.98%	5,550 $1.34 Million
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $7,955 - $9,104	-40 Reduced 0.72%	5,496 $1.24 Million
Q3 2021 Oct 26, 2021	BUY	$212.27 - $248.7 $127,362 - $149,220	600 Added 12.16%	5,536 $1.18 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $101,373 - $112,466	-434 Reduced 8.08%	4,936 $1.2 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $32,620 - $38,014	-147 Reduced 2.66%	5,370 $1.34 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $4.92 Million - $5.86 Million	-22,747 Reduced 80.48%	5,517 $1.27 Million
Q3 2020 Nov 09, 2020	BUY	$234.65 - $260.95 $113,335 - $126,038	483 Added 1.74%	28,264 $7.18 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $472,172 - $579,420	-2,387 Reduced 7.91%	27,781 $6.55 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $1.5 Million - $1.99 Million	8,240 Added 37.58%	30,168 $6.12 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $11,920 - $15,321	-63 Reduced 0.29%	21,928 $5.29 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $2.9 Million - $3.48 Million	16,658 Added 312.36%	21,991 $4.26 Million
Q2 2019 Jul 25, 2019	BUY	$166.7 - $195.41 $5,001 - $5,862	30 Added 0.57%	5,333 $983,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $452,175 - $509,700	2,500 Added 89.19%	5,303 $1.01 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $500,055 - $583,724	2,803 New	2,803 $546,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.

Account

Edge Capital Group, LLC Amgen Inc Transaction History